Clinical Hematology International

Volume 3, Issue 3, September 2021, Pages 116 - 118

The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma

Authors
Nadira Duraković1, 2, *, ORCID, Zinaida Perić1, 2, Sandra Bašić Kinda1, Lana Desnica1, Dino Dujmović1, Ivo Radman Livaja1, Ranka Serventi Seiwerth1, Igor Aurer1, 2, ORCID, Radovan Vrhovac1, 2, ORCID
1Department of Internal Medicine, University of Zagreb School of Medicine, Zagreb, Croatia
2Division of Hematology, Department of Internal Medicine, Zagreb, University Hospital Center Zagreb, Croatia
*Corresponding author. Email: nadira.durakovic@mef.hr
Corresponding Author
Nadira Duraković
Received 12 April 2021, Accepted 18 June 2021, Available Online 15 July 2021.
DOI
https://doi.org/10.2991/chi.k.210704.002How to use a DOI?
Keywords
Hodgkin lymphoma; alloHSCT; PET-CT
Copyright
© 2021 International Academy for Clinical Hematology. Publishing services by Atlantis Press International B.V.
Open Access
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)
View full text (HTML)

Journal
Clinical Hematology International
Volume-Issue
3 - 3
Pages
116 - 118
Publication Date
2021/07/15
ISSN (Online)
2590-0048
DOI
https://doi.org/10.2991/chi.k.210704.002How to use a DOI?
Copyright
© 2021 International Academy for Clinical Hematology. Publishing services by Atlantis Press International B.V.
Open Access
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

TY  - JOUR
AU  - Nadira Duraković
AU  - Zinaida Perić
AU  - Sandra Bašić Kinda
AU  - Lana Desnica
AU  - Dino Dujmović
AU  - Ivo Radman Livaja
AU  - Ranka Serventi Seiwerth
AU  - Igor Aurer
AU  - Radovan Vrhovac
PY  - 2021
DA  - 2021/07/15
TI  - The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma
JO  - Clinical Hematology International
SP  - 116
EP  - 118
VL  - 3
IS  - 3
SN  - 2590-0048
UR  - https://doi.org/10.2991/chi.k.210704.002
DO  - https://doi.org/10.2991/chi.k.210704.002
ID  - Duraković2021
ER  -